Reconsidering America’s Childhood Vaccine Recommendations

Childhood vaccines have somehow become one more subject that Americans are expected to discuss while wearing political jerseys. Question the government too aggressively, and one side calls you an anti-science crank. Defend established vaccines too confidently, and the other side assumes you receive handwritten Christmas cards from pharmaceutical executives. Such is the calm, reasonable state…

The Debate Over Testosterone Screening

Defense Secretary Pete Hegseth has ordered annual testosterone-deficiency screening for all active-duty and reserve personnel aged 30 and older. Testing will become part of the military’s Periodic Health Assessment, while younger service members may request it voluntarily. Hegseth says any resulting testosterone replacement therapy will remain optional. The July 15 Pentagon memorandum declares the requirement…

The GOP’s Planned Parenthood Fumble

Planned Parenthood is back to billing Medicaid for non-abortion services after a one-year federal reimbursement ban expired in early July 2026. That has pro-life groups furious, Planned Parenthood relieved, and Republican lawmakers once again discovering that campaign promises are much easier to shout into a microphone than to turn into durable law. Funny how that…

When Pills, Power, and Policy Collide

A federal court decision to block telehealth prescriptions for mifepristone might sound, at first glance, like one of those niche regulatory tweaks that only healthcare lawyers and policy wonks get excited about. But in reality, this is a ruling with massive ripple effects legally, culturally, and morally. To understand why, you have to look at…

Tariffs, Pills, and Politics: Will 100% Drug Tariffs Fix Anything or Break Everything?

If there’s one issue that reliably unites Americans across the political spectrum, it’s this: prescription drugs cost too much. Whether you’re paying out of pocket, dealing with insurance headaches, or watching premiums creep higher every year, the system feels expensive, opaque, and—at times—downright unfair. So, when President Trump steps in with a bold proposal like…

Conversion Therapy Bans: Protection or Overreach?

The phrase “conversion therapy” tends to end conversations before they even begin. It’s one of those terms that carries so much emotional and cultural weight that people often feel they already know where they’re supposed to land. Harmful. Discredited. Case closed. But once you slow down and actually examine what’s being debated—laws that prohibit certain…

Medicare by Choice: Smart Reform or Slow-Motion Takeover?

At its core, “Medicare by Choice” is an attempt to thread one of the most politically delicate needles in American policy: how to expand access to affordable healthcare without detonating the existing system in the process. Instead of replacing private insurance outright, the proposal would allow any American—regardless of age—to voluntarily enroll in Medicare. Employers…

America’s Childhood Obesity Crisis: You Can’t Inject Your Way Out of a Cultural Problem

America’s childhood obesity problem didn’t appear overnight, and it certainly won’t disappear because of a trendy new injection. Yet that seems to be where the conversation is heading. A growing debate is unfolding around the Trump administration’s “Make America Healthy Again” (MAHA) initiative and the increasing push to use GLP-1 drugs—medications like Ozempic and Wegovy—to…

Why Wyoming’s Ruling Gets the Moral Question Wrong

The recent decision by the Wyoming Supreme Court to strike down the state’s abortion restrictions rests on a pivotal claim: that abortion falls within a constitutional right to make one’s own healthcare decisions. That framing is not merely a legal conclusion. It’s a moral assertion with sweeping consequences. And it is, in most cases, profoundly…